Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia

Human Immunology

Volumn 69, Issue 10, 2008, Pages 666-674

  Hojjat Farsangi, Mohammad ^a   Jeddi Tehrani, Mahmood ^b,c   Amirzargar, Ali Akbar ^d   Razavi, Seyed Mohsen ^e   Sharifian, Ramazan Ali ^a   Rabbani, Hodjatallah ^b,c   Shokri, Fazel ^a,c,f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Avecinna Research Institute   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Chronic lymphocytic leukemia; DQB1; DRB1; Human leukocyte antigen; PCR

Indexed keywords

HLA A2 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HEAVY CHAIN; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT CODING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IRAN; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED;

EID: 54549118101     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.07.015     Document Type: Article

References (44)

1. Dighiero G., and Hamblin T.J. Chronic lymphocytic leukaemia. Lancet 371 (2008) 1017-1029
2. Byrd J.C., Stilgenbauer S., and Flinn I.W. Chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 1 (2004) 163-183
3. Faguet G.B. Chronic lymphocytic leukemia: an updated review. J Clin Oncol 12 (1994) 1974-1990
4. Moazzeni S.M., Amirzargar A.A., and Shokri F. HLA antigens in Iranian patients with B-cell chronic lymphocytic leukemia. Pathol Oncol Res 5 (1999) 142-145
5. Tamura K., Sawada H., Izumi Y., Fukuda T., Utsunomiya A., Ikeda S., et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol 67 (2001) 152-157
6. Cuttner J., Skerrett D., Rosina O., Troy K.M., Wallenstein S., and Spivack M. Increased incidence of HLA antigen B35 in patients with chronic lymphocytic leukemia. Leuk Res 18 (1994) 565-567
7. Bevan S., Catovsky D., Matutes E., Antunovic P., Auger M.J., Ben-Bassat I., et al. Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. Blood 96 (2000) 3982-3984
8. Segel G.B., and Lichtman M.A. Familial (inherited) leukemia, lymphoma, and myeloma: an overview. Blood Cells Mol Dis 32 (2004) 246-261
9. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102 (1998) 1515-1525
10. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., and Stevenson F.K. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94 (1999) 1848-1854
11. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840-1847
12. Maloum K., Davi F., Merle-Béral H., Pritsch O., Magnac C., Vuillier F., et al. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 96 (2000) 377-379
13. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194 (2001) 1639-1647
14. Klein U., Tu Y., Stolovitzky G.A., Mattioli M., Cattoretti G., Husson H., et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194 (2001) 1625-1638
15. Kaufman J.F., Auffray C., Korman A.J., Shackelford D.A., and Strominger J. The class II molecules of the human and murine major histocompatibility complex. Cell 36 (1984) 1-13
16. Suarez F., Lortholary O., Hermine O., and Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107 (2006) 3034-3044
17. Kilpatrick D.C., Dewar A.E., Stockdill G., Maginnis M., Jordan A., Neill G.W., et al. Histocompatibility antigen frequencies in patients with chronic lymphocytic leukaemia: possible identification of a subgroup with relatively benign disease. Scand J Haematol 33 (1984) 391-396
18. Dyer P.A., Ridway J.C., and Flanagan N.G. HLA-A, B and DR antigens in chronic lymphocytic leukaemia. Dis Markers 4 (1986) 231-237
19. Machulla H.K., Muller L.P., Schaaf A., Kujat G., Schonermarck U., and Langner J. Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DRB4:DQ8 haplotype in German patients. Int J Cancer 92 (2001) 203-207
20. Jones H.P., and Whittaker J.A. Chronic lymphatic leukaemia: an investigation of HLA antigen frequencies and white cell differential counts in patients, relatives and controls. Leuk Res 15 (1991) 543-579
21. Dorak M.T., Machulla H.K., Hentschel M., Mills K.I., Langner J., and Burnett A.K. Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia. Int J Cancer 65 (1996) 134-139
22. Linet M.S., Bias W.B., Dorgan J.F., McCaffrey L.D., and Humphrey R.L. HLA antigens in chronic lymphocytic leukemia. Tissue Antigens 31 (1988) 71-78
23. Lech-Maranda E., Juszczynski P., Szmigielska-Kaplon A., Jamroziak K., Balcerczak E., and Robak T. Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia?. Haematologica 92 (2007) 710-711
24. Tiwari J.L., and Terasaki P.I. HLA and disease associations (1985), Springer-Verlag, Berlin 293-303
25. Hojjat Farsangi M., Jeddi-Tehrani M., Razavi S.M., Sharifian R.A., Shamsian Khoramabadi A., Rabbani H., et al. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression. Iran J Immunol 5 (2008) 25-35
26. Molica S., De Rossi G., Luciani M., and Levato D. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Haematologica 80 (1995) 176-193
27. Amirzargar A., Mytilineos J., Farjadian S., Doroudchi M., Scherer S., Opelz G., et al. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 62 (2001) 1234-1238
28. Olerup O., and Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP] in 2 hours: an alternative to serological DR-typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39 (1992) 225-235
29. Schneider S., Roessli D., and Excoffier L. Arlequin Version 2000: a software for population genetics data analysis (2000), Genetics and Biometry Laboratory, University of Geneva, Geneva, Switzerland
30. Ferrer A., Ollila J., Tobin G., Nagy B., Thunberg U., Aalto Y., et al. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Cancer Genet Cytogenet 153 (2004) 69-72
31. Timonova L.A., and Rumiantsev A.G. Class I and II HLA antigens in children with acute lymphoblastic leukemia. Gematol Transfuziol 34 (1989) 19-22
32. Von Fliedner V.E., Sultan-Khan Z., and Jeannet M. HLA-DRw antigens associated with acute leukemia. Tissue Antigens 16 (1980) 399-404
33. Amirzargar A.A., Khosravi F., Dianat S.S., Alimoghadam K., Ghavamzadeh F., Ansaripour B., et al. Association of HLA class II allele and haplotype frequencies with chronic myelogenous leukemia and age-at-onset of the disease. Pathol Oncol Res 13 (2007) 47-51
34. Jones E.H., Biggar R.J., Nkrumah F.K., and Lawler S.D. Study of the HLA system in Burkitt's lymphoma. Hum Immunol 1 (1980) 207-210
35. Le Dieu R., and Gribben J. Vaccine- and immune-based therapy in chronic lymphocytic leukemia. Semin Oncol 33 (2006) 220-229
36. Gallego A., Vargas J.A., Castejon R., Citores M.J., Romero Y., Millan I., et al. Production of intracellular IL-2, TNF-α, and IFN-γ by T cells in CLL. Cytometry B Clin Cytom 56 (2003) 23-29
37. Rezvany M.R., Jeddi-Tehrani M., Rabbani H., Rudén U., Hammarström L., Osterborg A., et al. Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia. Br J Haematol 111 (2000) 230-238
38. Rezvany M.R., Jeddi-Tehrani M., Rabbani H., Lewin N., Avila-Cariño J., Osterborg A., et al. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. Br J Haematol 111 (2000) 608-617
39. Tobin G., Thunberg U., Laurell A., Karlsson K., Aleskog A., Willander K., et al. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome. Haematologica 90 (2005) 465-469
40. Ritgen M., Lange A., Stilgenbauer S., Dohner H., Bretscher C., Bosse H., et al. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia. Blood 101 (2003) 2049-2053
41. Ghia P., Guida G., Stella S., Gottardi D., Geuna M., Strola G., et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 101 (2003) 1262-1269
42. Mainou-Fowler T., Dignum H.M., Proctor S.J., and Summerfield G.P. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leuk (CLL). Leuk Lymphoma 45 (2004) 455-462
43. Nückel H., Rebmann V., Dürig J., Dührsen U., and Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 105 (2005) 1694-1698
44. Hviid T.V., and Christiansen O.B. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G-possible implications for human reproduction and autoimmune disease. Hum Immunol 66 (2005) 688-699